EirGenix Inc. announced the establishment of the company's Corporate Governance Committee with Lee-Cheng Liu: President & CEO, EirGenix, Inc; Ming-Thaur Chang: Independent Director, DBS Bank (Taiwan) Ltd.; Fu-Shiow Yin: Independent Director, Foresee Pharmaceuticals Co. Ltd.; Ming-Shen Chen: Professor of Finance at National Taiwan University.; and Po-Chih Chen: Senior Advisors to the President, effective December 28, 2022. Mr. Ming-Shen Chen is the chairman of first term Corporate Governance Committee.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
86.3 TWD | +9.94% | +8.83% | -14.13% |
05-15 | EirGenix Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-22 | EirGenix Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.13% | 815M | |
-1.54% | 91.26B | |
-2.63% | 38.17B | |
+70.22% | 26.74B | |
-12.67% | 15.93B | |
-4.79% | 13.37B | |
-10.50% | 11.77B | |
+187.82% | 10.92B | |
-49.11% | 10.27B | |
+1.42% | 8.69B |
- Stock Market
- Equities
- 6589 Stock
- News EirGenix Inc.
- Eirgenix Inc. Announces Establishment of Corporate Governance Committee